135 related articles for article (PubMed ID: 38752177)
1. Diagnosis rates, therapeutic characteristics, lifestyle, and cancer screening habits of patients with diabetes mellitus in a highly deprived region in Hungary: a cross-sectional analysis.
Pártos K; Major D; Dósa N; Fazekas-Pongor V; Tabak AG; Ungvári Z; Horváth I; Barta I; Pozsgai É; Bodnár T; Fehér G; Lenkey Z; Fekete M; Springó Z
Front Endocrinol (Lausanne); 2024; 15():1299148. PubMed ID: 38752177
[TBL] [Abstract][Full Text] [Related]
2. Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment for people with type 2 diabetes in England: A cross-sectional study.
Bidulka P; Mathur R; Lugo-Palacios DG; O'Neill S; Basu A; Silverwood RJ; Charlton P; Briggs A; Smeeth L; Adler AI; Douglas IJ; Khunti K; Grieve R
Diabetes Obes Metab; 2023 Jan; 25(1):282-292. PubMed ID: 36134467
[TBL] [Abstract][Full Text] [Related]
3. Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population.
Grabner M; Peng X; Geremakis C; Bae J
J Manag Care Spec Pharm; 2015 Dec; 21(12):1204-12. PubMed ID: 26679969
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and correlates of diagnosed and undiagnosed type 2 diabetes mellitus and pre-diabetes in older adults: Findings from the Irish Longitudinal Study on Ageing (TILDA).
Leahy S; O' Halloran AM; O' Leary N; Healy M; McCormack M; Kenny RA; O' Connell J
Diabetes Res Clin Pract; 2015 Dec; 110(3):241-9. PubMed ID: 26520567
[TBL] [Abstract][Full Text] [Related]
5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of impaired fasting glucose and undiagnosed diabetes mellitus and associated risk factors among adults living in a rural Koladiba town, northwest Ethiopia.
Worede A; Alemu S; Gelaw YA; Abebe M
BMC Res Notes; 2017 Jul; 10(1):251. PubMed ID: 28683811
[TBL] [Abstract][Full Text] [Related]
7. Prescription trends and the selection of initial oral antidiabetic agents for patients with newly diagnosed type 2 diabetes: a nationwide study.
Liu CH; Chen ST; Chang CH; Chuang LM; Lai MS
Public Health; 2017 Nov; 152():20-27. PubMed ID: 28719837
[TBL] [Abstract][Full Text] [Related]
8. Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
Whyte MB; Hinton W; McGovern A; van Vlymen J; Ferreira F; Calderara S; Mount J; Munro N; de Lusignan S
PLoS Med; 2019 Oct; 16(10):e1002942. PubMed ID: 31589609
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study.
Hadaegh F; Bozorgmanesh MR; Ghasemi A; Harati H; Saadat N; Azizi F
BMC Public Health; 2008 May; 8():176. PubMed ID: 18501007
[TBL] [Abstract][Full Text] [Related]
10. Lifestyle factors associated with type 2 diabetes and use of different glucose-lowering drugs: cross-sectional study.
Ulrichsen SP; Mor A; Svensson E; Larsen FB; Thomsen RW
PLoS One; 2014; 9(11):e111849. PubMed ID: 25369331
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Random blood glucose: a robust risk factor for type 2 diabetes.
Bowen ME; Xuan L; Lingvay I; Halm EA
J Clin Endocrinol Metab; 2015 Apr; 100(4):1503-10. PubMed ID: 25650899
[TBL] [Abstract][Full Text] [Related]
13. Social inequalities in prevalence of diagnosed and undiagnosed diabetes and impaired glucose regulation in participants in the Health Surveys for England series.
Moody A; Cowley G; Ng Fat L; Mindell JS
BMJ Open; 2016 Feb; 6(2):e010155. PubMed ID: 26857106
[TBL] [Abstract][Full Text] [Related]
14. Preventive Metformin Monotherapy Medication Prescription, Redemption and Socioeconomic Status in Hungary in 2018-2019: A Cross-Sectional Study.
Nagy C; Juhász A; Pikó P; Diószegi J; Paragh G; Szabó Z; Varga O; Ádány R
Int J Environ Res Public Health; 2021 Feb; 18(5):. PubMed ID: 33668088
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of undiagnosed diabetes mellitus and associated factors among adult residents of Mizan Aman town, Southwest Ethiopia: Community-based cross-sectional study.
Atrese T; Fekadu L; Kune G; Shita A; Woldemikael K
PLoS One; 2024; 19(5):e0302167. PubMed ID: 38713690
[TBL] [Abstract][Full Text] [Related]
16. Participation in structured diabetes mellitus self-management education program and association with lifestyle behavior: results from a population-based study.
Carmienke S; Baumert J; Gabrys L; Heise M; Frese T; Heidemann C; Fink A
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32205327
[TBL] [Abstract][Full Text] [Related]
17. Socioeconomic Inequalities of Undiagnosed Diabetes in a Resource-Poor Setting: Insights from the Cross-Sectional Bangladesh Demographic and Health Survey 2011.
Hasan MM; Tasnim F; Tariqujjaman M; Ahmed S
Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30609855
[TBL] [Abstract][Full Text] [Related]
18. Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
Sarfo FS; Akassi J; Agyei M; Kontoh S; Ovbiagele B
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105304. PubMed ID: 32992189
[TBL] [Abstract][Full Text] [Related]
19. Undiagnosed type 2 diabetes is common - intensified screening of established risk groups is imperative in Sweden: the SDPP cohort.
Gudjonsdottir H; Tynelius P; Stattin NS; Méndez DY; Lager A; Brynedal B
BMC Med; 2024 Apr; 22(1):168. PubMed ID: 38637767
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of delayed clinical diagnosis of Type 2 diabetes: a longitudinal cohort study.
Gopalan A; Mishra P; Alexeeff SE; Blatchins MA; Kim E; Man AH; Grant RW
Diabet Med; 2018 Dec; 35(12):1655-1662. PubMed ID: 30175870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
